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Abstract The e⁄cient delivery of short interfering RNAs (si-
RNAs) into cells provides a powerful approach to study cellular
functions. SiRNAs were coupled to the membrane permeant
peptides (MPPs) penetratin and transportan to improve their
uptake by cells. Thiol-containing siRNAs corresponding to lu-
ciferase, or green £uorescent protein (GFP) transgenes, were
synthesized and conjugated to penetratin or transportan via a
disul¢de bond that is labile in the reducing environment of the
cytoplasm. These MPP-siRNAs e⁄ciently reduced transient
and stable expression of reporter transgenes in several mamma-
lian cell types in a high proportion of cells, and demonstrated
equivalent or better delivery characteristics than cationic lipo-
somes with fewer manipulations.
* 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Recently, a naturally occurring process was discovered in
fungi and plants that involves sequence-speci¢c post-transcrip-
tional silencing of gene expression [1]. Subsequently this pro-
cess was shown to occur in bacterial and animal cells and the
term RNA interference (RNAi) was coined for this phenom-
enon [1,2]. The silencing ‘triggers’ for RNAi are long double-
stranded RNA (dsRNA) molecules complementary to mRNA
sequences that are introduced into cells either experimentally
or are derived from endogenous sources such as viruses, trans-
genes or cellular genes (transposons) [2]. These dsRNA mol-
ecules are processed into discrete short interfering RNA (si-
RNA) fragments that are 21^25 nucleotides in length by an
enzyme known as Dicer [3]. The siRNAs are subsequently
presented to a 500 kDa ribonuclear protein complex known
as the RNA-induced silencing complex (RISC) comprised of
nucleases, helicases and RNA-dependent polymerases to tar-
get speci¢c mRNAs for destruction.
Long dsRNA sequences may activate the interferon re-
sponse and 2-5A antisense pathways, but generally cause
non-speci¢c mRNA degradation in cells [4], whereas siRNAs
induce sequence-speci¢c degradation of only targeted mRNAs
[3]. Tuschl and coworkers have shown that 21-nucleotide du-
plexes corresponding to a luciferase transgene introduced in
di¡erent cell types cause speci¢c inhibition of the luciferase
gene expression [5]. Large dsRNAs in turn cause complete
arrest of gene expression within the cells masking any se-
quence-speci¢c e¡ects.
SiRNAs are polyanions and unassisted permeation across
lipid bilayers is negligible. DsRNA can be delivered to Caeno-
rhabditis elegans by feeding or soaking [6], however in mam-
malian cells siRNAs are typically delivered using cationic lipo-
somes [5]. Although the use of liposomes has shown some
success, the major disadvantages of this delivery method for
nucleic acids are that a number of cell types (examples include
dendritic and HUVEC endothelial cells) cannot be transfected
using liposomes at an e⁄ciency that yields a signi¢cant bio-
logical e¡ect [7,8], and in each experiment several manipula-
tions of the cells are required. The development of a method
for direct targeting of siRNA molecules from the extracellular
environment to the cytoplasm may signi¢cantly enhance re-
search using siRNAs to silence genes in cultured and somatic
cells.
Membrane permeant peptides (MPPs) are suitable candi-
dates for the delivery of relatively large molecules, such as
nucleic acids, peptides, proteins and even paramagnetic par-
ticles up to 200 nm in diameter, to cells [9^12]. These short
amphipathic peptides have been shown to translocate across
lipid bilayers in an energy-independent manner [9]. Here we
describe a conjugate for directly targeting siRNAs to the cy-
toplasm of cells, with delivery across the plasma membrane
using the MPPs, penetratin or transportan. We report the
synthesis of disul¢de-linked MPP-siRNA and demonstrate
the ability of these compounds to enter cells and in£uence
transiently and stably expressed transgenes in cells.
2. Materials and methods
2.1. Oligonucleotides
Four sets of complementary siRNAs were purchased from Dhar-
macon Research (Lafayette, CO, USA). SiRNAs were designed to
target the GL2 luciferase mRNA (acc. no. X65324), corresponding
to the coding region 153^173 relative to the ¢rst nucleotide of the
start codon (5P-rCrGrUrArCrGrCrGrGrArArUrArCrUrUrCrGrAT-
T-3P and 5P-rUrCrGrArArGrUrArUrUrCCrGrCrGrUrArCrGTT-3P)
and the green £uorescent protein (GFP) mRNA (acc. no. U55762),
corresponding to the coding region 540^565 (5P-rArCrUrArCrCr-
ArGrCrArGrArArCrArCrCrCrCTT-3P and 5P-rGrGrGrGrUrGrUr-
UrCrUrGrCrUrGrGrUrArGrUTT-3P). A pair of GL2 siRNAs and
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GFP siRNAs were chemically modi¢ed with a thiol group at the 5P
end of one RNA strand and a 5P Cy3 on the complementary strand.
2.2. Solid phase peptide synthesis
Peptide synthesis for penetratin (CRQIKIWFQNRRMKWKK)
and transportan (CLIKKALAALAKLNIKLLYGASNLTWG) was
carried out on a 0.25 mmol scale (manual synthesis) starting from
either an Fmoc (9-£uorenylmethoxycarbonyl)-lysine WANG resin,
or an Fmoc-glycine WANG resin (substitution value 0.75 mmol/g
resin) (Auspep, Parkville, Australia). All Fmoc amino acids in 4-
fold excess were assembled using 2-(1-H-benzotriazol-1-yl)-1,1,3,3-tet-
ramethyl-uronium (HBTU) and diisopropylethylamine (DIPEA) as
coupling reagents (Auspep). The Fmoc groups protecting the amine
groups on amino acids were removed using 50% piperidine in dime-
thylformamide (DMF) [13]. Both penetratin and transportan were
synthesized with a cysteine residue at the N-terminus. Both peptides
were cleaved from their resins by tri£uoroacetic acid (TFA) and scav-
engers (TFA:H2O:phenol:triisopropylsilane, 88:5:5:2) under nitro-
gen at 0‡C for 1 h [13]. The products were precipitated with diethyl
ether, dissolved in 50% acetonitrile, lyophilized and redissolved in
water. The crude peptides were then puri¢ed by reverse phase-high
performance liquid chromatography (RP-HPLC) using a semi-prepa-
rative column (Vydac C18, 300 AV , 10U250 mm) and the peptide purity
was checked using an analytical column (Vydac C4, 300 AV , 4.6U250
mm) (Auspep). A linear gradient starting with 0.1% TFA in water and
¢nishing with 90% acetonitrile in water and 0.1% TFA was run over
30 min. The peptide peaks were detected by absorbance at 280 nm,
collected, lyophilized and dissolved in water for further use.
2.3. Synthesis of siRNA-MPP conjugates
For annealing of siRNAs, 35 WM of single strands were incubated
in annealing bu¡er (100 mM potassium acetate, 30 mM HEPES^
KOH at pH 7.4, 2 mM magnesium acetate) for 1 min at 90‡C fol-
lowed by 1 h incubation at 37‡C. Annealed siRNAs were introduced
into cells using Lipofectamine 2000 (Invitrogen, CA, USA). The an-
nealed siRNAs containing thiol groups were desalted by incubating
the hybridization mix for 7 min on ice in a pre-set 1% agarose in 100
mM glucose well in an Eppendorf tube (by leaving a 100 Wl tip in the
molten agarose mix and allowing it to set). The desalted siRNAs were
supplemented with 1 vol reaction bu¡er (10 mM HEPES, 1 mM
ethylenediamine tetraacetic acid (EDTA), pH 8.0) to adjust the ¢nal
concentration of the siRNAs to 17.5 WM. Equimolar amounts of
siRNAs, MPPs (penetratin or transportan) and the thiol oxidant di-
amide (Sigma, USA) were mixed and incubated for 1 h at 40‡C. The
MPP-siRNA/diamide solution was then mixed with culture media and
incubated immediately with cells. MPP-DNA conjugates prepared as
described above were s 95% pure with an 80% yield following HPLC
puri¢cation and matrix-assisted laser desorption/ionization-time of
£ight (MALDI-TOF) mass spectrometry (not shown).
2.4. Cell culture and transfections
Cells were grown as previously described [13]. Brie£y, COS-7 cells,
C166-GFP and EOMA-GFP cells were grown in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 10% inactivated fetal
calf serum (FCS) and CHO-AA8-Luc Tet-O¡ cells were grown in
minimum essential medium (alpha modi¢cation) with 10% FCS (Gib-
co, USA). In addition to 100 units ml31 penicillin, and 100 Wg ml31
streptomycin, C166-GFP and EOMA-GFP cells were supplemented
with 200 Wg ml31 G418 (Gibco) and CHO-AA8-Luc Tet-O¡ cells with
100 Wg ml31 G418 and 100 Wg ml31 hygromycin B (Gibco). 24 h
before transfection at V80% con£uency, the cells were trypsinized,
diluted 1:3 with fresh medium (1^5U105 cells ml31) and transferred
to 24-well plates (300 Wl per well). Cotransfection of reporter plasmids
and siRNAs in COS-7 cells was carried out by incubation with Lipo-
fectamine 2000 in serum-free DMEM for 6 h, followed by replace-
ment with fresh media containing 10% fetal bovine serum (FBS), as
described by the manufacturer. The concentrations of the plasmids
per well were 1.0 Wg for pGL2 and 0.1 Wg for pCB11 (Rluc expressed
by the SV40 promoter) (Promega, USA). The siRNAs were supple-
mented in all cell lines at 25 nM concentrations by addition directly in
the cell culture media, or by transfection with Lipofectamine 2000, as
above. Penetratin-siRNAs and transportan-siRNAs were supple-
mented in 25 nM concentrations by addition directly to the cell cul-
ture media, or by transfection with Lipofectamine 2000, as above.
COS-7 cells were also treated with siRNAs, which were directly added
to the cell culture media 24 h after the transfection with transgenic
reporter plasmids. Luciferase expression in COS-7 cells was assayed
using a dual luciferase kit (Promega) to measure both ¢re£y luciferase
and Renilla luciferase activities (Rluc), allowing ease of comparison
between transfection experiments. CHO-AA8-Luc Tet-O¡ cells were
incubated with the siRNAs continuously for up to 3 days, and C166-
GFP and EOMA-GFP cells were incubated with siRNAs continu-
ously for up to 7 days. Gene silencing was monitored by Western
blotting, £ow cytometry and £uorescence microscopy.
2.5. Sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and immunoblotting
SDS^PAGE and immunoblotting were carried out as previously
described [13]. In each lane 20 Wg of protein was loaded as quantitated
using the bicinchoninic acid (BCA) assay. Quantitative densitometry
to calculate the area under the peak, which was representative of the
intensity of the band, was carried out on the original image using
NIH image software.
2.6. Flow cytometry
C166-GFP and EOMA-GFP cells grown in 24-well plates were
treated with GFP siRNAs delivered using Lipofectamine 2000, pene-
tratin and transportan, for 1, 3 and 7 days after which the cells were
prepared for £ow cytometry as described [14].
2.7. Fluorescence microscopy
C166-GFP and EOMA-GFP cells grown in 35 mm dishes were
treated with GFP siRNAs delivered using Lipofectamine 2000, pene-
tratin and transportan for 1 day, 3 days and 7 days. Photographs of
the cells were acquired using a Zeiss inverted confocal microscope
with a Plan-Neo£uar 40U/1.3 oil DIC objective and 488 nm LASER
excitation, and Zeiss Imaging Software with equal exposure times.
3. Results
SiRNAs 21 nucleotides in length were designed to be com-
plementary to a region of the ¢re£y luciferase or GFP trans-
genes [1,5]. One set of the siRNAs was introduced into cells
by liposomes and the other set of siRNAs was chemically
modi¢ed with a free thiol group at the 5P end of one strand
so that it could react with a free thiol group from a cysteine
amino acid on an MPP (Fig. 1).
Two experiments were carried out to test the e⁄ciency of
delivery of the MPP-siRNA on its own, or in the presence of
Lipofectamine 2000. In the ¢rst experiment ¢re£y luciferase
(GL2) siRNAs or MPP-siRNAs were introduced into the cells
together with transgenes during Lipofectamine 2000-mediated
transfection, while in the second experiment siRNAs or MPP-
siRNAs were introduced 24 h following transgene transfec-
tion. In control experiments cells were transfected with only
the ¢re£y or Renilla luciferase transgenes to determine the
basal (exogenous) luciferase activity within the cells. The de-
livery of siRNAs linked to penetratin by transfection using
Lipofectamine 2000 gave an approximately 75% decrease in
luciferase activity, while transportan-linked siRNA resulted in
a markedly smaller (V40%) decrease in luciferase activity
(Fig. 2A). The luciferase activity was reduced approximately
92% in cells treated with siRNAs delivered using Lipofectam-
ine (Fig. 2A). These results suggest that MPP-siRNAs may
not be ideal substrates for cationic liposome-mediated trans-
fection. SiRNAs unassisted by penetratin or Lipofectamine
could not gain entrance to the cells and the luciferase activity
remained the same as in cells transfected only with the trans-
genes. The activity of the Renilla luciferase remained constant
in cells treated with or without the siRNAs, suggesting that
the decrease of the ¢re£y luciferase activity was due to the
sequence-speci¢c binding of the siRNAs to its mRNA.
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The second experiment tested whether MPP-siRNAs could
speci¢cally decrease luciferase activity when added to the cell
culture media (i.e. the MPP-siRNAs were not transfected us-
ing Lipofectamine 2000) 24 h after transfection of the lucifer-
ase transgene. Penetratin-siRNA and transportan-siRNA con-
jugates were able to enter the cells without transfection using
Lipofectamine 2000, and e⁄ciently decreased luciferase activ-
ity (Fig. 2B). Similar levels of luciferase activity were observed
with siRNAs delivered by Lipofectamine and MPP-siRNAs.
Unmodi¢ed siRNAs did not decrease luciferase activity.
The ability of the MPP-conjugated siRNAs to silence en-
dogenous gene expression in cells was then investigated in
Chinese hamster ovary (CHO-AA8-Luc Tet-O¡) cells that
stably expressed luciferase. Lipofectamine-delivered siRNAs
decreased luciferase activity by 36% 48 h after the treatment
(Fig. 3). However, the basal luciferase activity returned to
normal levels 24 h later. Penetratin- and transportan-delivered
siRNAs decreased the luciferase levels by 53 and 63% respec-
tively, within the initial 24 h after treatment and this decrease
remained stable for up to 3 days (Fig. 3). These results suggest
that transfection of CHO-AA8-Luc Tet-O¡ cells with siRNAs
using Lipofectamine 2000 results in a signi¢cantly lower e⁄-
ciency of transfection than when siRNAs are delivered as
MPP-siRNAs. Unassisted delivery of siRNAs and mock treat-
ment of cells with media did not alter the basal luciferase
activity within the cells.
To further test the speci¢city and e⁄ciency of the silencing
e¡ects of MPP-linked siRNAs, C166-GFP and EOMA-GFP
cells stably expressing GFP were transfected with GFP si-
RNAs using Lipofectamine or treated with penetratin-siRNAs
and transportan-siRNAs. Silencing of GFP was monitored for
1, 3 and 7 days after the treatment.
Fluorescence microscopy was used initially to show the
general decrease in £uorescence of cells treated with siRNAs
delivered by Lipofectamine and MPP (Fig. 4A^D). The £uo-
rescence of cells treated with media only was unchanged over
7 days. The intensity of the cell £uorescence decreased dra-
matically with prolonged exposure to siRNAs, which was
most evident after 7 days of siRNA treatment (Fig. 4B, C).
Western blots were then used to show the qualitative de-
crease of GFP following treatment of C166-GFP and EOMA-
Fig. 1. Synthesis of disul¢de-linked MPPs and siRNAs. MPPs and siRNAs were synthesized with a thiol group attached as described in Section
2. The single-stranded RNAs were annealed together to form a duplex and the duplexes mixed with MPP in equimolar amounts for the conju-
gation reaction. SiRNAs had a thiol group attached at the 5P end of one strand, and a Cy3 £uorescent label attached at the 5P end of the com-
plementary strand to enable the identi¢cation of the siRNA within cells by £uorescence microscopy. The reaction between the thiol groups on
the siRNA and the MPP was catalyzed by the oxidant diamide as shown.
Fig. 2. E¡ects of siRNAs on luciferase expression in COS-7 cells.
Experiments were performed with pGL2 control and pCB11 report-
er plasmids. The data were averaged from three independent experi-
ments and expressed as ratios of normalized target to control lucif-
erase. GL2 siRNAs were delivered by liposomes (using
Lipofectamine 2000) or MPPs (penetratin and transportan). Control
incubations were carried out with media only. A: COS-7 cells were
cotransfected with siRNAs and reporter plasmids at the same time
point. B: COS-7 cells were treated with siRNAs 24 h after transfec-
tion of the reporter plasmid.
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GFP with siRNAs delivered by Lipofectamine, or MPPs.
Cells treated with media only showed abundant GFP in the
absence of RNAi (Fig. 4E). The silencing of GFP expression
was more pronounced in the EOMA-GFP cell line, where
treatment with MPP-siRNAs resulted in an average of 86^
97% decrease in protein expression. In the C166-GFP cell
line the amount of GFP was silenced by an average of 67^
80%, which was less than in EOMA-GFP cells, presumably
due to the presence of multiple GFP transgenes in the stably
transfected cell line.
As before EOMA-GFP cells were treated with siRNAs de-
livered by Lipofectamine and MPPs and the delivery e⁄cien-
cies were compared by quantitating GFP expression using
£ow cytometry. Cells transfected with siRNAs using Lipofect-
amine 2000 decreased the cell £uorescence by 65%, implying
that 65% of cells were transfected after 7 days, while penetra-
tin and transportan siRNA resulted in 73 and 80% decrease
(implying 73^80% transfection e⁄ciency) in cell £uorescence,
respectively (Fig. 4F).
4. Discussion
Here we show that siRNAs can be delivered directly to the
cytoplasm when conjugated to MPPs, such as penetratin or
transportan. SiRNAs delivered in this way are capable of
silencing the expression of either transfected or endogenous
genes. The salient features of this system are as follows: (i) the
peptide facilitates transport across the plasma membrane and
the siRNA-MPPs are freely translocated into the cytoplasm,
(ii) the disul¢de bond is reduced in the cytoplasm, releasing
the bioactive siRNA to cause sequence-speci¢c mRNA degra-
dation, and (iii) the uptake of the conjugate is rapid and
occurs directly through the membrane without the need for
classical receptor-mediated uptake or endo- or pinocytosis.
While we have not characterized whether the siRNAs remain
intact after delivery to the cell, it is possible that the two
strands of the siRNA partially dissociate during delivery of
the conjugate to the cytoplasm, although this would not nec-
essarily a¡ect the function of the siRNA, as single-strand
antisense siRNAs are able to silence endogenous gene expres-
sion in cells [15].
The data obtained from the experiments involving trans-
fection of COS-7 cells with MPP-siRNAs using Lipofectamine
2000 indicate that a lower percentage of luciferase transgene
silencing had occurred when MPP-siRNAs were transfected
into COS-7 cells compared to cells transfected with siRNAs,
suggesting that the transfection of MPP-siRNAs was less e⁄-
cient than with siRNAs. One explanation for this may be that
during transfection with Lipofectamine, the delivery is af-
fected by the overall charge of the MPP-siRNA molecule,
which is more positive than the siRNA itself, because MPPs
are positively charged. A negative overall charge is required
for the e⁄cient transfection of nucleic acids with cationic lipo-
somes. On the other hand, the e⁄ciency of silencing of lucif-
erase activity in COS-7 cells following the incubation of cells
with MPP-siRNAs present in the media was similar to that
involving Lipofectamine 2000-mediated transfection of si-
RNAs, indicating that MPP-siRNAs were just as e¡ective as
Lipofectamine-transfected siRNAs in silencing luciferase in
COS-7 cells. In CHO-AA8-Luc Tet-O¡ cells, however, the
percentage of luciferase activity silenced on each of the
3 days following incubation of the cells with MPP-siRNAs
was markedly superior to the silencing following transfection
with Lipofectamine 2000, suggesting that MPP-siRNAs enter
CHO-AA8 cells more e⁄ciently than Lipofectamine-trans-
fected siRNAs. Following treatment with MPP-siRNAs, or
transfection with siRNAs, the expression of GFP in EOMA-
GFP and C166-GFP mouse ¢broblast cell lines was silenced
Fig. 3. E¡ect of siRNAs delivered in CHO-AA8-Luc Tet-O¡ cells by liposomes and MPP. CHO-AA8-Luc Tet-O¡ cells stably expressing lucif-
erase were treated with 25 nM concentrations of siRNAs delivered by transfection with Lipofectamine 2000 for 6 h, or by incubating in media
containing penetratin-siRNAs or transportan-siRNAs for up to 3 days. Luciferase activity was assayed every 24 h and plotted in arbitrary lu-
minescence units. Control incubations were carried out with siRNAs alone and media only.
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with greater e⁄ciency using MPP-siRNAs than transfection
with siRNAs when examined by Western blot, which is a
measure of the absolute level of GFP expression. In examin-
ing EOMA-GFP cells by £uorescence-activated cell sorter
(FACS) to identify the percentage of cells receiving the
MPP-siRNA, the numbers of cells exhibiting GFP silencing
was similar to or slightly better than the number receiving
Lipofectamine-transfected siRNAs, suggesting that in these
cells both MPP-siRNA and Lipofectamine-delivered siRNA
underwent similar transfection e⁄ciencies.
Fig. 4. Silencing of GFP in mouse ¢broblast cell lines stably expressing GFP. C166-GFP and EOMA-GFP cell lines were treated with 25 nM
GFP siRNAs delivered by liposomes or MPP. A^D: Double £uorescence staining of EOMA-GFP cells treated with siRNAs delivered using
Lipofectamine (A), penetratin (B), transportan (C), or media only (D), as a control. siRNAs were labeled with the red £uorophore Cy3, and
green £uorescence from GFP was also visualized using confocal £uorescence microscopy after 3 and 7 days. E: Western blot of C166-GFP and
EOMA-GFP cells transfected with GFP siRNA duplex using Lipofectamine 2000, or treated with penetratin-siRNAs, transportan-siRNAs or
with media only. Densitometric quantitation of the amount of GFP detected by Western blot for each lane as a percentage of the average in-
tensity of the media control is shown for each cell line (#). RNAi of GFP was carried out for 7 days during which GFP protein expression
was detected with a GFP-speci¢c antibody. Only results from day 7 are shown. F: The £uorescence of EOMA-GFP cells treated with or with-
out siRNAs was measured after day 1, day 3 and day 7 by £ow cytometry.
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In conclusion, constitutively expressed luciferase and GFP
genes were successfully silenced in our experiments in a high
proportion of cells of di¡erent types with the penetratin- or
transportan-siRNA conjugates. Although there is an initial
cost associated with synthesizing MPPs, the siRNAs bearing
a thiol group were only marginally more expensive than stan-
dard siRNAs. Moreover, once MPPs had been generated the
cost of producing MPP-siRNAs was minimal, and therefore
MPPs could be a powerful and relatively inexpensive tool for
e¡ective delivery of siRNAs to multiple cell types, and may
complement the use of transfection with cationic liposomes,
especially where multiple manipulations of the cells are to be
avoided such as in high-throughput strategies. Our observa-
tion that CHO-AA8 cells were more e⁄ciently treated with
MPP-siRNAs than with siRNAs transfected using Lipofect-
amine 2000 suggests that other cell types not e⁄ciently tar-
geted with standard transfection protocols may also be suit-
able for speci¢c inhibition of gene expression using MPP-
siRNAs. This may open the way to study gene function by
modulating naturally occurring processes in mammalian cells,
ultimately leading to the development of screens to analyze
cellular functions, or to new gene-speci¢c therapeutic agents
for treating disease.
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